Trial Design Issues in SLE Joel Schiffenbauer FDA/CDER DAAODP.
Balloon-Expandable TAVR in Inoperable Patients With Severe Symptomatic Native Aortic Valve Stenosis: The PARTNER Trial Cohort B 2-Year Results.
